Michael Cherny

Q: What is Michael Cherny's success rate?

Michael Cherny currently has a success rate of 93.6729280183539.

Q: What is the average return of Michael Cherny's calls?

Their stock ratings have generated an average return of 14.423314701347481.

Leerink Partners | Healthcare

Michael Cherny is an analyst from Leerink Partners specializing in the Healthcare sector. Ranked #1527 out of 4508 analysts, they have issued 13 stock ratings with a success rate of 93.67% and an average return of 14.42%.

With 13 ratings to date, Michael Cherny is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 93.67% and an average return of 14.42%, highlighting promising potential as their track record develops further.

#1527

Out of 4508

Total Ratings

+93.67%

Success Rate

+14.42%

Average Return

Recent Ratings Analysis

CERT

Buy

Jan 06, 2026

Target

$13.00

Current

$9.33

Performance

-2.51%

Michael Cherny rated CERT as Outperform on Jan 06, 2026, setting a price target of 13. Shares have remained stable near 9.33, leaving the 13 target still in play.

DGX

Buy

Oct 21, 2025

Target

$210.00

Current

$174.44

Performance

-5.52%

On Oct 21, 2025, DGX was given a Outperform rating by Michael Cherny, with a target price of 210. Despite the Buy call, shares fell from 174.44 to 174.44, challenging the optimistic stance.

MCK

Buy

Sep 24, 2025

Target

$850.00

Current

$816.06

Performance

7.29%

MCK received a Outperform rating from Michael Cherny on Sep 24, 2025, aiming for 850. Momentum has favored the Buy call, with shares climbing from 816.06 to 816.06, rewarding those who trusted the recommendation.

PINC

Sell

Aug 19, 2025

Target

$21.00

Current

$28.26

Performance

7.82%

On Aug 19, 2025, Michael Cherny published a Underperform outlook on PINC, with a target of 21. Investors who followed the Sell rating avoided losses as the stock weakened.

CAH

Buy

Aug 12, 2025

Target

$186.00

Current

$201.11

Performance

37.46%

Michael Cherny on Aug 12, 2025 assigned CAH a Outperform rating, with a price target of 186. The Buy call aligned well with market performance, producing a gain of 37.46%.

PGNY

Buy

Jul 08, 2025

Target

$28.00

Current

$26.99

Performance

11.21%

On Jul 08, 2025, Michael Cherny reaffirmed PGNY with a Outperform rating, targeting 28. The recommendation was supported by strong follow-through as the stock rose from 26.99 to 26.99.

MEDP

Hold

Mar 24, 2025

Target

$330.00

Current

$595.00

Performance

79.98%

MEDP was rated Market Perform by Michael Cherny on Mar 24, 2025, with a price objective of 330. Despite caution, upside momentum rewarded risk-takers with gains to 595.

HIMS

Hold

Feb 25, 2025

Target

$40.00

Current

$31.69

Performance

-20.50%

On Feb 25, 2025, Michael Cherny initiated coverage on HIMS with a Market Perform rating and target of 40. The rating matched the stock’s inability to hold above 31.69.

CVS

Buy

Feb 13, 2025

Target

$75.00

Current

$80.30

Performance

20.99%

Michael Cherny issued a Outperform recommendation for CVS on Feb 13, 2025, price target set at 75. Investors following the Buy call captured upside momentum, with shares now at 80.3.

DOCS

Buy

Feb 07, 2025

Target

$90.00

Current

$43.79

Performance

-44.73%

On Feb 07, 2025, DOCS was evaluated by Michael Cherny, who gave a Outperform rating and target of 90. Investors saw limited payoff as shares fell short of the 90 target.

ACCD

Hold

Jan 08, 2025

Target

$0.00

Current

$7.02

Performance

2.33%

Michael Cherny rated ACCD as Market Perform on Jan 08, 2025, setting a price target of null. The Hold stance appears justified, as shares hovered around 7.02 with a 2.33% move.

HSIC

Buy

Jan 06, 2025

Target

$84.00

Current

$77.64

Performance

8.19%

On Jan 06, 2025, HSIC was given a Buy rating by Michael Cherny, with a target price of 84. The stock rallied 8.19% after the rating, narrowing the gap to the target of 84 and validating the bullish stance.

ALGN

Buy

Jan 06, 2025

Target

$280.00

Current

$172.79

Performance

-21.06%

ALGN received a Outperform rating from Michael Cherny on Jan 06, 2025, aiming for 280. The rating hasn’t played out as hoped, with the stock trading 21.06% below expectations.

PDCO

Hold

Dec 11, 2024

Target

$31.35

Current

$31.33

Performance

-0.22%

On Dec 11, 2024, Michael Cherny published a Market Perform outlook on PDCO, with a target of 31.35. Sideways action left the Hold view intact, with no major move since 31.33.

IQV

Buy

Nov 19, 2024

Target

$248.00

Current

$242.41

Performance

26.70%

Michael Cherny on Nov 19, 2024 assigned IQV a Outperform rating, with a price target of 248. The Buy call aligned well with market performance, producing a gain of 26.70%.

ICLR

Buy

Nov 19, 2024

Target

$255.00

Current

$181.38

Performance

-7.27%

On Nov 19, 2024, Michael Cherny reaffirmed ICLR with a Outperform rating, targeting 255. Shares slid 7.27% despite the recommendation, highlighting downside risks.

COR

Buy

Oct 07, 2024

Target

$275.00

Current

$335.69

Performance

52.93%

COR was rated Outperform by Michael Cherny on Oct 07, 2024, with a price objective of 275. A bullish response from the market helped close the gap of -60.69 to the target.

RCM

Hold

Aug 01, 2024

Target

$14.30

Current

$14.31

Performance

1.27%

On Aug 01, 2024, Michael Cherny initiated coverage on RCM with a Market Perform rating and target of 14.3. The stock’s lack of movement around 14.31 aligned with a cautious approach.

Frequency Asked Questions

Who is Michael Cherny?

Michael Cherny is an analyst from Leerink Partners specializing in the Healthcare sector.

What is Michael Cherny's success rate?

Michael Cherny currently has a success rate of +93.67%.

How many ratings has Michael Cherny issued?

Michael Cherny has issued 13 stock ratings so far.

What is the average return of Michael Cherny's calls?

Their stock ratings have generated an average return of +14.42%.

What is Michael Cherny's ranking?

Michael Cherny is ranked #1527 out of 4508 analysts.

What types of ratings does Michael Cherny give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Michael Cherny?

You can follow Michael Cherny by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Michael Cherny?

Their latest rating was a Buy on CERT issued on 2026-01-06.